Lubricant Eye Drops: Clinical Trials

106 trials of Lubricant Eye Drops, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

71 completed, 14 unknown, 7 terminated, 3 active not recruiting. 34 Not applicable, 33 Phase 4, 20 Phase 2, 17 Phase 3, 6 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable34Completed 27, Enrolling by invitation 2, Not yet recruiting 2, Terminated 2, Unknown 1
Phase 433Completed 24, Active not recruiting 2, Recruiting 2, Unknown 2, Withdrawn 2, Terminated 1
Phase 220Completed 6, Unknown 6, Terminated 4, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 317Completed 10, Unknown 6, Recruiting 1
Phase 16Completed 3, Unknown 2, Terminated 1
Early Phase 12Completed 2

Follow Lubricant Eye Drops: new trials by email Literature Review of Lubricant Eye Drops trials Research Report on Lubricant Eye Drops

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Behavioral Intervention (Baduanjin Alone or Laughter Exercise Plus Artificial Tears) Versus Artificial Tear on Dry Eye Disease: a Randomised Controlled Trial
Baduanjin, Laughter exercise, Artificial tears - Dry Eye Disease (DED)
Not applicableNot yet recruitingZhongshan Ophthalmic Center, Sun Yat-sen University5402027-01-012026-04-13
Evaluation of Ophtholic Ultra for Ocular Surface Protection After Cataract Surgery
Ophtholic Ultra, Standard postoperative therapy without lubricating eye drops - Dry Eye Disease (DED)
Phase 4Active not recruitingKazakh Eye Research Institute602026-08-242026-10-09
Imaging the Effects of Netarsudil (Rhopressa) on the Trabecular Meshwork in Glaucoma and Ocular Hypertension
Netarsudil Ophthalmic Solution (Rhopressa), Artificial Tears (AT) - Glaucoma, Ocular Hypertension
Phase 4RecruitingIndiana University502026-06-052026-06-11
Eyelid Taping Alone Versus Taping With Lubricant Eye Drops for Perioperative Corneal Protection
Hypoallergenic Eyelid Taping, Hypoallergenic Eyelid Taping With Lubricant Eye Drops - Corneal Injury, Exposure Keratopathy
Not applicableNot yet recruitingFatih Sultan Mehmet Training and Research Hospital2002026-06-012026-05-07
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Surabgene Lomparvovec, Sham, Topical Steroid - Diabetic Retinopathy
Phase 2 / Phase 3RecruitingAbbVie5762026-06-012026-10-16
0.01% and 0.025% Atropine Eye Drops Combined Auricular Acupoint Stimulation on Myopia Control and Corneal Endothelium Change
Auricular acupoint stimulation, 0.01% concentration atropine drops, 0.025% atropine eye drops - Acupressure
Not applicableEnrolling by invitationChina Medical University Hospital4202026-04-112026-06-04
A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease
BRM421 Ophthalmic Solution, 0.03%, Artificial Tear, BRM421 Ophthalmic Solution, 0.06% - Dry Eye Disease (DED), Keratoconjunctivitis Sicca
Phase 2Not yet recruitingBRIM Biotechnology Inc.992025-12-012025-10-20
Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLT
Netarsudil ophthalmic solution 0.02%, Artificial tears - Primary Open Angle Glaucoma or Ocular Hypertension
Phase 4Active not recruitingEast Coast Institute for Research702025-06-272026-06-10
Topical Insulin for Ocular Surface Interface in Dry Eye Disease
Artificial tear, insulin human - Dry Eye, Insulin Sensitivity
Phase 4CompletedKhyber Teaching Hospital1282025-04-142026-08-14
Evaluation of the Effectiveness of Auricular Acupuncture in Improving Dry Eye Symptoms in University Students
Auricular acupuncture, Sham auricular acupuncture, Artificial Tears (AT) - Dry Eye Symptoms
Not applicableCompletedUniversity of Medicine and Pharmacy at Ho Chi Minh City502025-03-152025-09-24
A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes
0.003% AR-15512 ophthalmic solution, Artificial tears - Dry Eye Disease
Phase 3CompletedAlcon Research552025-01-152026-03-17
The Effect of Eye Care With Artificial Tears and Normal Saline on Ocular Surface Disease in Mechanically Ventilated Pediatric Patients
Eye Care with Artificial Tears, Eye Care with Normal Saline - Ocular Surface Disease
Not applicableCompletedMarmara University422024-11-012025-06-03
A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease
0.003% AR-15512 ophthalmic solution, Artificial Tears - Dry Eye Disease
Phase 3CompletedAlcon Research802024-10-082026-03-27
Treating Meibomian Gland Disease in a Pediatric Population
Low level light treatment, warm compress and artificial tear - Dry Eye Disease, Meibomian Gland Disease
Not applicableEnrolling by invitationIllinois College of Optometry152024-10-012025-11-14
Efficacy of Pilocarpine As a Secretagogue Versus Artificial Tears for the Treatment of Dry Eye
Pilocarpine, artificial tears - Dry Eye Disease (DED)
Not applicableCompletedAl-Azhar University402024-10-012024-12-30
A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression
Mirvetuximab Soravtansine, Lubricating Eye Drops, Prednisolone acetate ophthalmic suspension 1% eye drops - Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive
Phase 2Active not recruitingAbbVie1082024-07-292026-08-21
Traditional Chinese Medicine Ultrasonic Atomization Treatment for Dry Eye Disease
TCM ultrasonic atomization treatment with herbal Compound Decoction (CD), TCM ultrasonic atomization treatment with Dendrobii Caulis (DC), TCM ultrasonic atomization treatment with Houttuynia Cordata (HC) - Dry Eye Syndromes
Not applicableCompletedChinese University of Hong Kong2002024-07-282026-03-19
YM-101 Eye Drops in the Treatment of Dry Eye Syndrome
YM-101 high dose + artificial tear, YM-101 low dose + artificial tear, placebo + artificial tear - Dry Eye
Early Phase 1CompletedEye & ENT Hospital of Fudan University302024-04-232026-03-16
Medical vs Acupuncture for Dry Eye
Artificial tears, Traditional Chinese Medicine Acupuncture - Dry Eye, Acupuncture
Not applicableCompletedNadide Koca902024-01-152025-09-22
Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution
NCX 470, Placebo - Open Angle Glaucoma
Phase 2 / Phase 3CompletedNicox Ophthalmics, Inc.182023-12-122025-09-08

Showing 20 of 106. Sign in to see all of them.

Conditions studied

Dry Eye Syndromes (43)  ·  Glaucoma (9)  ·  Ocular Hypertension (7)  ·  Conjunctivitis, Allergic (6)  ·  Glaucoma, Open-Angle (6)  ·  Keratoconjunctivitis Sicca (6)  ·  Conjunctivitis (5)  ·  Pain (5)  ·  Meibomian Gland Dysfunction (4)  ·  Adenoviridae Infections (3)  ·  Cataract (2)  ·  Conjunctivitis, Viral (2)  ·  Corneal Ulcer (2)  ·  Exfoliation Syndrome (2)  ·  Eye Diseases (2)

Sponsors

Alcon Research (8)  ·  Allergan (8)  ·  University Hospital of Patras (4)  ·  Aristotle University Of Thessaloniki (3)  ·  Massachusetts Eye and Ear Infirmary (3)  ·  AbbVie (2)  ·  Barbara Burgos Blasco (2)  ·  Baylor College of Medicine (2)  ·  He Eye Hospital (2)  ·  Peschke GmbH (2)  ·  Wills Eye (2)  ·  Aciex Therapeutics, Inc. (1)  ·  Adapt Produtos Oftalmológicos Ltda. (1)  ·  Al-Azhar University (1)  ·  Alexandria University (1)

Countries

United States (53)  ·  Greece (7)  ·  Canada (5)  ·  China (5)  ·  Spain (4)  ·  Turkey (Türkiye) (3)  ·  Belgium (2)  ·  Brazil (2)  ·  Egypt (2)  ·  Ethiopia (2)  ·  Hong Kong (2)  ·  Mexico (2)  ·  Pakistan (2)  ·  Taiwan (2)  ·  United Kingdom (2)

Top investigators

Bala Ambati (2)  ·  Barbara Burgos Blasco, MD, PhD (2)  ·  Emmanuel Eric Pazo (2)  ·  Reza Dana, MD, MPH, MSc (2)  ·  Yvette Viscuso (2)  ·  Ahmad M Fahmy, O.D. (1)  ·  Anastasios GP Konstas, MD, PhD (1)  ·  Bita Esmaeli, MD (1)  ·  Bushra Kanwal, MPO (1)  ·  Buys M Yvonne, MD FRCSC (1)  ·  Carol B Toris, PhD (1)

Results publications

PMID 11237914, PMID 12649304, PMID 12823990, PMID 15161834, PMID 15286669, PMID 15832184, PMID 20973888, PMID 23445780, PMID 23665202, PMID 25179431, PMID 27119078, PMID 27294831, PMID 27929721, PMID 28190580, PMID 28280298, PMID 28319106, PMID 28475124, PMID 29075094, PMID 29671255, PMID 29731019, PMID 31518657, PMID 31800960, PMID 31834617, PMID 32280196, PMID 9778415, PMID 12719068, PMID 15948994, PMID 16021174, PMID 16565005, PMID 16765803, PMID 16900027, PMID 16952090, PMID 17054241, PMID 17457183, PMID 17457184, PMID 17531694, PMID 17720054, PMID 20092592, PMID 21821228, PMID 22331114, PMID 22511024, PMID 23599118, PMID 24403819, PMID 24695688, PMID 24886701, PMID 25248295, PMID 25260889, PMID 26783543, PMID 29284427, PMID 29799915

NIH funding

2023 (1)